Understand the source comparison
AHK-Cu SubQ vs IM Injection Route: Research Comparison
Bioavailability 87% (stable across subjects) 62–91% (variable by muscle group, depth, and subject anatomy) SubQ delivers predictable absorption Tmax (Time to Peak) 45–60 minutes 30–90 minutes (dependent on muscle perfusion) SubQ produces consistent plasma curv
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Bioavailability
- 87% (stable across subjects)
- 62–91% (variable by muscle group, depth, and subject anatomy)
- SubQ delivers predictable absorption
- Tmax (Time to Peak)
- 45–60 minutes
- 30–90 minutes (dependent on muscle perfusion)
- SubQ produces consistent plasma curves
- Tissue Trauma
- Minimal (single tissue plane)
- Moderate (3–4 tissue planes crossed)
- SubQ reduces inflammatory confounds
- Contamination Risk
- 0.4% under aseptic protocol
- 1.8% under identical aseptic protocol
- SubQ cuts infection risk by 78%
- Operator Skill Requirement
- Low (anatomically consistent target)
- Moderate-High (depth precision critical)
- SubQ tolerates technique variation better
- Needle Gauge
- 25–27G (less mechanical disruption)
- 22–23G (required for fascial penetration)
- SubQ uses finer needles